Who is BlueRock?
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
What Are We Doing?
Our foundational science harnesses the ability to create and then direct the differentiation of universal pluripotent stem cells into authentic, functional cells that can be used as allogeneic cellular therapies to treat a broad array of diseases. We can also further engineer these cells, enabling them to produce enzymes, antibodies, and other proteins for additional therapeutic benefit.
We are passionate about delivering on the promise of cellular and gene therapy, shaping the future of cellular medicine, and delivering new therapies to millions of patients with treatment options.
We are seeking individuals who are collaborative, thrive in a fun and dynamic culture, and are steadfast in the commitment to advance cutting-edge cellular therapies to impact patients’ lives.
Our Pipeline Vision:
Neurology:
BlueRock is advancing an innovative pipeline of cell therapies in neurology, focused on addressing the urgent needs of patients with neurodegenerative and neurological disorders. Our lead neurology program, bemdaneprocel (DA01), is a first-in-class, allogeneic cell therapy designed to replace lost dopaminergic neurons in patients with Parkinson’s disease. This program is currently in phase 3 development with the exPDite-2 clinical trial ongoing in the US, Canada, and Australia. Additional neurology pipeline assets, including DA02 and MG0X, are in research phase targeting other high-impact neurological conditions. Our goal is to restore function, slow or halt disease progression, and transform the standard of care for patients with debilitating neurological diseases.
Ophthalmology:
BlueRock is expanding its innovative cell therapy portfolio into ophthalmology, with a focus on addressing unmet medical needs in retinal diseases. Our lead ophthalmology program, OpCT001, is a first-in-class, allogeneic cell therapy candidate designed to replace lost or damaged retinal pigment epithelial (RPE) cells in patients with advanced retinal disorders, such as geographic atrophy secondary to age-related macular degeneration (AMD). OpCT001 leverages our CELL+GENE™ platform to generate authentic, functional RPE cells from pluripotent stem cells, with the goal of restoring vision and halting disease progression.
BlueRock is committed to scientific excellence, operational rigor, and the highest standards of ethics and compliance. The company fosters an inclusive, collaborative environment where innovation, diversity, and patient-centricity drive every decision.
About the Role:
The Director of Clinical Operations Quality is responsible to lead the development and evolution of core SOP’s, processes and templates of Operational documents necessary to support the planning and execution of our clinical studies. This critical role will bring In-depth knowledge of and ability to interpret and apply GCP EU, FDA and ICH regulations and guidelines, a track record of developing fit-for-purpose SOP’s and standards in growing organizations. This individual will also serve as a Subject Matter Expert (SME) to clinical operations staff and key BlueRock team members offering guidance and assisting in applications to our clinical studies.
#LI-AL1
BlueRock Therapeutics Company Culture Highlights
Winner of Boston Business Journal's Best Places to Work (Mid-size Company) 2023
Winner of Comparably's Award for Best Company for Diversity 2022
Winner of Comparably's Award for Best Company for Women 2022
Winner of Comparably's Award for Best CEO 2022
BlueRock Therapeutics is ranked in the top 5% of companies for Overall Culture on Comparably.
Engineering Department is ranked in the top 5% of companies for Overall Culture on Comparably.
Check us out on Comparably: https://www.comparably.com/companies/bluerock-therapeutics
Follow us on Linkedin: https://www.linkedin.com/company/bluerocktx/
Equal Opportunity Workplace: At BlueRock, we welcome and support differences and diversity and we are proud to be an equal opportunity workplace. Please let us know if you require disability-related accommodation or other grounds protected by human rights legislation during the recruitment process so that we can work with you to meet your needs.
If an employer mentions a salary or salary range on their job, we display it as an "Employer Estimate". If a job has no salary data, Rise displays an estimate if available.
Experienced SDET with strong JavaScript/Node.js automation skills and familiarity with AI-assisted testing tools needed to advance Bitly’s automation frameworks and quality practices.
Senior QA Engineer needed to drive manual and automated testing for DroneSense's public-safety drone platform, ensuring reliable releases for first responders.
GeneFab is looking for a Document Control & Training Manager to lead Veeva-based document control and training operations supporting cGMP manufacturing and quality systems in Alameda, CA.
Centene is hiring a board-certified MD/DO in Georgia to serve as a remote Medical Director focused on utilization management, quality improvement, clinical review, and provider collaboration for a large managed care business unit.
Experienced QA Automation Engineer needed to build and maintain end-to-end and server-side test automation for a growing healthcare SaaS platform.
Experienced safety professional needed to lead OSHA compliance, process safety (PSM), environmental oversight and injury prevention for Jack Link's Alpena production facility.
Humata Health is hiring a QA Engineer to validate AI-driven healthcare workflows, drive testing efforts across sprints, and triage customer-reported issues in a hybrid/remote role.
VahatiCor is hiring a hands-on Quality Engineer with direct catheter device experience and ISO 13485 expertise to lead quality activities for catheter manufacturing and validation.
Pfizer is hiring a Quality Risk Management Manager in Kalamazoo to lead QRM programs, maintain QRM tools and libraries, and provide guidance to site teams to ensure compliant, risk-based quality practices.
Super.com seeks an experienced QA Analyst II to own test design and execution across product verticals, ensuring reliable, high-quality releases in a remote-first setting.
Experienced healthcare quality professional needed to lead evidence-based population health programs, ensure compliance with accreditation and CMS standards, and drive measurable improvements across assigned measures.
WebFX is hiring remote Expert Advisors in sports medicine and physical therapy to review and validate clinical content on a flexible, part-time contract basis.
Eurofins is seeking a Cell-Based Assay Scientist to run ELISA and cell-culture based GMP testing and maintain high-quality documentation at its Chesterfield/St. Louis laboratory.
At BlueRock, our mission is to create authentic cellular medicines to reverse devastating diseases, with the vision of improving the human condition.
4 jobs